Australia In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Published : Dec-2017

No. of Pages : 544

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 9
2 Introduction 14
2.1 What Is This Report About? 14
2.2 In Vitro Diagnostics (IVD) Market Segmentation 14
2.3 Definitions of Markets Covered in the Report 18
3 In Vitro Diagnostics Market, Australia 41
3.1 In Vitro Diagnostics Market, Australia, Revenue ($m), 2010-2024 41
3.2 In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2017 43
3.3 In Vitro Diagnostics Market, Australia, Category Contribution by Revenue ($m), 2017 44
3.4 In Vitro Diagnostics Market, Australia, Category Comparison by Revenue ($m), 2009-2023 45
3.5 In Vitro Diagnostics Market, Australia, Revenue ($m), 2010-2017 47
3.6 In Vitro Diagnostics Market, Australia, Revenue ($m), 2017-2024 49
3.7 In Vitro Diagnostics Market, Australia, Volume (Units), 2010-2024 51
3.8 In Vitro Diagnostics Market, Australia, Volume (Units), 2010-2017 53
3.9 In Vitro Diagnostics Market, Australia, Volume (Units), 2017-2024 55
3.10 In Vitro Diagnostics Market, Australia, Company Share by Revenue ($m), 2017 57
4 Clinical Chemistry Market, Australia 59
4.1 Clinical Chemistry Market, Australia, Revenue Mix ($m), 2017 59
4.2 Clinical Chemistry Market, Australia, Segment Contribution (%), 2017 60
4.3 Clinical Chemistry Market, Australia, Revenue ($m), 2010-2017 62
4.4 Clinical Chemistry Market, Australia, Revenue ($m), 2017-2024 64
4.5 Clinical Chemistry Market, Australia, Volume (Units), 2010-2017 98
4.6 Clinical Chemistry Market, Australia, Volume (Units), 2017-2024 100
4.7 Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), 2017 126
4.8 Clinical Chemistry Market, Australia, Company Share by Revenue ($m), 2017 127
5 Genetic Testing Market, Australia 129
5.1 Genetic Testing Market, Australia, Revenue Mix ($m), 2017 129
5.2 Genetic Testing Market, Australia, Segment Contribution (%), 2017 130
5.3 Genetic Testing Market, Australia, Revenue ($m), 2010-2017 131
5.4 Genetic Testing Market, Australia, Revenue ($m), 2017-2024 133
5.5 Genetic Testing Market, Australia, Distribution Share by Revenue ($m), 2017 135
5.6 Genetic Testing Market, Australia, Company Share by Revenue ($m), 2017 136
6 Hematology Market, Australia 138
6.1 Hematology Market, Australia, Revenue Mix ($m), 2017 138
6.2 Hematology Market, Australia, Segment Contribution (%), 2017 139
6.3 Hematology Market, Australia, Revenue ($m), 2010-2017 140
6.4 Hematology Market, Australia, Revenue ($m), 2017-2024 142
6.5 Hematology Market, Australia, Volume (Units), 2010-2017 168
6.6 Hematology Market, Australia, Volume (Units), 2017-2024 170
6.7 Hematology Market, Australia, Distribution Share by Revenue ($m), 2017 188
6.8 Hematology Market, Australia, Company Share by Revenue ($m), 2017 189
7 Histology And Cytology Market, Australia 191
7.1 Histology And Cytology Market, Australia, Revenue Mix ($m), 2017 191
7.2 Histology And Cytology Market, Australia, Segment Contribution (%), 2017 192
7.3 Histology And Cytology Market, Australia, Revenue ($m), 2010-2017 193
7.4 Histology And Cytology Market, Australia, Revenue ($m), 2017-2024 195
7.5 Histology And Cytology Market, Australia, Distribution Share by Revenue ($m), 2017 197
7.6 Histology And Cytology Market, Australia, Company Share by Revenue ($m), 2017 198
8 Immuno Chemistry Market, Australia 200
8.1 Immuno Chemistry Market, Australia, Revenue Mix ($m), 2017 200
8.2 Immuno Chemistry Market, Australia, Segment Contribution (%), 2017 201
8.3 Immuno Chemistry Market, Australia, Revenue ($m), 2010-2017 203
8.4 Immuno Chemistry Market, Australia, Revenue ($m), 2017-2024 205
8.5 Immuno Chemistry Market, Australia, Volume (Units), 2010-2017 239
8.6 Immuno Chemistry Market, Australia, Volume (Units), 2017-2024 241
8.7 Immuno Chemistry Market, Australia, Distribution Share by Revenue ($m), 2017 275
8.8 Immuno Chemistry Market, Australia, Company Share by Revenue ($m), 2017 276
9 Infectious Diagnostics Market, Australia 278
9.1 Infectious Diagnostics Market, Australia, Revenue Mix ($m), 2017 278
9.2 Infectious Diagnostics Market, Australia, Segment Contribution (%), 2017 279
9.3 Infectious Diagnostics Market, Australia, Revenue ($m), 2010-2017 281
9.4 Infectious Diagnostics Market, Australia, Revenue ($m), 2017-2024 284
9.5 Infectious Diagnostics Market, Australia, Volume (Units), 2010-2017 331
9.6 Infectious Diagnostics Market, Australia, Volume (Units), 2017-2024 334
9.7 Infectious Diagnostics Market, Australia, Distribution Share by Revenue ($m), 2017 381
9.8 Infectious Diagnostics Market, Australia, Company Share by Revenue ($m), 2017 382
10 Microbiology Culture Market, Australia 384
10.1 Microbiology Culture Market, Australia, Revenue Mix ($m), 2017 384
10.2 Microbiology Culture Market, Australia, Segment Contribution (%), 2017 385
10.3 Microbiology Culture Market, Australia, Revenue ($m), 2010-2017 387
10.4 Microbiology Culture Market, Australia, Revenue ($m), 2017-2024 389
10.5 Microbiology Culture Market, Australia, Distribution Share by Revenue ($m), 2017 399
10.6 Microbiology Culture Market, Australia, Company Share by Revenue ($m), 2017 400
11 Overview of Key Companies in Australia, In Vitro Diagnostics Market 402
11.1 F. Hoffmann-La Roche Ltd 402
11.2 Abbott Laboratories 402
11.3 Beckman Coulter Inc 402
11.4 Thermo Fisher Scientific Inc 402
11.5 Siemens Healthcare GmbH 403
11.6 bioMerieux SA 403
11.7 Becton Dickinson and Co 403
11.8 Sysmex Corp 404
11.9 Hologic Inc 404
11.10 Qiagen NV 404
12 In Vitro Diagnostics Market Pipeline Products 405
13 Financial Deals Landscape 409
13.1 Acquisition 409
13.2 Asset Transactions 411
13.3 Debt Offerings 413
13.4 Equity Offerings 417
13.5 Merger 435
13.6 Partnerships 437
14 Recent Developments 471
14.1 Corporate Communications 471
14.2 Financial Announcements 491
14.3 Government and Public Interest 506
14.4 Legal And Regulatory 507
14.5 Other Significant Developments 509
14.6 Product News 521
14.7 Strategy And Business Planning 530
15 Appendix 531
15.1 Research Methodology 532
15.2 GlobalData Consulting 536
15.3 Contact Us 537
15.4 Disclaimer 537

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, 2010-2024 48
Table 2: In Vitro Diagnostics Market, Australia, Category Contribution by Revenue ($m), 2017 50
Table 3: In Vitro Diagnostics Market, Australia, Category Comparison by Revenue ($m), 2009-2023 52
Table 4: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 54
Table 5: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 56
Table 6: In Vitro Diagnostics Market, Australia, Volume (Units), 2010-2024 58
Table 7: In Vitro Diagnostics Market, Australia, Volume (Units), Historic, 2010-2017 60
Table 8: In Vitro Diagnostics Market, Australia, Volume (Units), Forecast, 2017-2024 62
Table 9: In Vitro Diagnostics Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 64
Table 10: Clinical Chemistry Market, Australia, Segment Contribution (%), 2017 67
Table 11: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 69
Table 12: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 71
Table 13: Blood Test Strips - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 73
Table 14: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 75
Table 15: Enzyme Chemistry Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 77
Table 16: Feces Tests - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 79
Table 17: Substrates Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 81
Table 18: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 83
Table 19: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 85
Table 20: Urine Testing - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 87
Table 21: Blood Test Strips - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 89
Table 22: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 91
Table 23: Enzyme Chemistry Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 93
Table 24: Feces Tests - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 95
Table 25: Substrates Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 97
Table 26: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 99
Table 27: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 101
Table 28: Urine Testing - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 103
Table 29: Clinical Chemistry Market, Australia, Volume (Units), Historic, 2010-2017 105
Table 30: Clinical Chemistry Market, Australia, Volume (Units), Forecast, 2017-2024 107
Table 31: Blood Test Strips - Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 109
Table 32: Clinical Chemistry Analyzers Market, Australia, Volume (Units), Historic, 2010-2017 111
Table 33: Enzyme Chemistry Reagents Market, Australia, Volume (Units), Historic, 2010-2017 113
Table 34: Feces Tests - Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 115
Table 35: Substrates Market, Australia, Volume (Units), Historic, 2010-2017 117
Table 36: Urine Testing - Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 119
Table 37: Blood Test Strips - Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 121
Table 38: Clinical Chemistry Analyzers Market, Australia, Volume (Units), Forecast, 2017-2024 123
Table 39: Enzyme Chemistry Reagents Market, Australia, Volume (Units), Forecast, 2017-2024 125
Table 40: Feces Tests - Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 127
Table 41: Substrates Market, Australia, Volume (Units), Forecast, 2017-2024 129
Table 42: Urine Testing - Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 131
Table 43: Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 132
Table 44: Clinical Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 134
Table 45: Genetic Testing Market, Australia, Segment Contribution (%), 2017 136
Table 46: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 138
Table 47: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 140
Table 48: Genetic Testing Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 141
Table 49: Genetic Testing Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 143
Table 50: Hematology Market, Australia, Segment Contribution (%), 2017 145
Table 51: Hematology Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 147
Table 52: Hematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 149
Table 53: Hematology Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 151
Table 54: Hematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 153
Table 55: Hematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 155
Table 56: Hematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 157
Table 57: Hemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 159
Table 58: Immunohematology Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 161
Table 59: Hematology Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 163
Table 60: Hematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 165
Table 61: Hematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 167
Table 62: Hematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 169
Table 63: Hemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 171
Table 64: Immunohematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 173
Table 65: Hematology Market, Australia, Volume (Units), Historic, 2010-2017 175
Table 66: Hematology Market, Australia, Volume (Units), Forecast, 2017-2024 177
Table 67: Hematology Analyzers Market, Australia, Volume (Units), Historic, 2010-2017 179
Table 68: Hematology Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 181
Table 69: Hematology Reagents Market, Australia, Volume (Units), Historic, 2010-2017 183
Table 70: Hemostasis Market, Australia, Volume (Units), Historic, 2010-2017 185
Table 71: Hematology Analyzers Market, Australia, Volume (Units), Forecast, 2017-2024 187
Table 72: Hematology Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 189
Table 73: Hematology Reagents Market, Australia, Volume (Units), Forecast, 2017-2024 191
Table 74: Hemostasis Market, Australia, Volume (Units), Forecast, 2017-2024 193
Table 75: Hematology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 194
Table 76: Hematology Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 196
Table 77: Histology And Cytology Market, Australia, Segment Contribution (%), 2017 198
Table 78: Histology And Cytology Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 200
Table 79: Histology And Cytology Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 202
Table 80: Histology And Cytology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 203
Table 81: Histology And Cytology Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 205
Table 82: Immuno Chemistry Market, Australia, Segment Contribution (%), 2017 208
Table 83: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 210
Table 84: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 212
Table 85: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 214
Table 86: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 216
Table 87: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 218
Table 88: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 220
Table 89: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 222
Table 90: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 224
Table 91: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 226
Table 92: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 228
Table 93: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 230
Table 94: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 232
Table 95: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 234
Table 96: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 236
Table 97: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 238
Table 98: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 240
Table 99: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 242
Table 100: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 244
Table 101: Immuno Chemistry Market, Australia, Volume (Units), Historic, 2010-2017 246
Table 102: Immuno Chemistry Market, Australia, Volume (Units), Forecast, 2017-2024 248
Table 103: Complement Deficiency Tests Market, Australia, Volume (Units), Historic, 2010-2017 250
Table 104: Diabetes Assays Market, Australia, Volume (Units), Historic, 2010-2017 252
Table 105: Disease Specific Immunochemistry Market, Australia, Volume (Units), Historic, 2010-2017 254
Table 106: Endocrinology Tests Market, Australia, Volume (Units), Historic, 2010-2017 256
Table 107: IgE Allergy Blood Tests Market, Australia, Volume (Units), Historic, 2010-2017 258
Table 108: Immunochemistry Analyzers Market, Australia, Volume (Units), Historic, 2010-2017 260
Table 109: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 262
Table 110: Vitamins Tests Market, Australia, Volume (Units), Historic, 2010-2017 264
Table 111: Complement Deficiency Tests Market, Australia, Volume (Units), Forecast, 2017-2024 266
Table 112: Diabetes Assays Market, Australia, Volume (Units), Forecast, 2017-2024 268
Table 113: Disease Specific Immunochemistry Market, Australia, Volume (Units), Forecast, 2017-2024 270
Table 114: Endocrinology Tests Market, Australia, Volume (Units), Forecast, 2017-2024 272
Table 115: IgE Allergy Blood Tests Market, Australia, Volume (Units), Forecast, 2017-2024 274
Table 116: Immunochemistry Analyzers Market, Australia, Volume (Units), Forecast, 2017-2024 276
Table 117: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 278
Table 118: Vitamins Tests Market, Australia, Volume (Units), Forecast, 2017-2024 280
Table 119: Immuno Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 281
Table 120: Immuno Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 283
Table 121: Infectious Diagnostics Market, Australia, Segment Contribution (%), 2017 286
Table 122: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 288
Table 123: Infectious Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 291
Table 124: Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 294
Table 125: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 296
Table 126: Hepatitis Test Kits Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 298
Table 127: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 300
Table 128: Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 302
Table 129: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 304
Table 130: Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 306
Table 131: Polymerase Chain Reaction (PCR) Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 308
Table 132: Post Streptococcus pyogenes Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 310
Table 133: Retrovirus Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 312
Table 134: Treponema pallidum Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 314
Table 135: Chlamydia trichomatis Diagnostic Test Kits Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 316
Table 136: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 318
Table 137: Hepatitis Test Kits Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 320
Table 138: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 322
Table 139: Infectious Diagnostics Multiple Parameter Test Kits Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 324
Table 140: Infectious Diagnostics Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 326
Table 141: Mycobacterium tuberculosis Diagnostic Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 328

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, 2010-2024 47
Figure 2: In Vitro Diagnostics Market, Australia, Revenue Mix ($m), 2017 49
Figure 3: In Vitro Diagnostics Market, Australia, Category Contribution (%), 2017 50
Figure 4: In Vitro Diagnostics Market, Australia, Category Comparison by Revenue ($m), 2009-2023 51
Figure 5: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 53
Figure 6: In Vitro Diagnostics Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Figure 7: In Vitro Diagnostics Market, Australia, Volume (Units), 2010-2024 57
Figure 8: In Vitro Diagnostics Market, Australia, Volume (Units), Historic, 2010-2017 59
Figure 9: In Vitro Diagnostics Market, Australia, Volume (Units), Forecast, 2017-2024 61
Figure 10: In Vitro Diagnostics Market, Australia, Company Share (%) 2017 63
Figure 11: Clinical Chemistry Market, Australia, Revenue Mix ($m), 2017 65
Figure 12: Clinical Chemistry Market, Australia, Segment Contribution (%), 2017 66
Figure 13: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 68
Figure 14: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 70
Figure 15: Blood Test Strips - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 72
Figure 16: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 74
Figure 17: Enzyme Chemistry Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 76
Figure 18: Feces Tests - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 78
Figure 19: Substrates Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 80
Figure 20: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 82
Figure 21: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 84
Figure 22: Urine Testing - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 86
Figure 23: Blood Test Strips - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 88
Figure 24: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 90
Figure 25: Enzyme Chemistry Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 92
Figure 26: Feces Tests - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 94
Figure 27: Substrates Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 96
Figure 28: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 98
Figure 29: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 100
Figure 30: Urine Testing - Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 102
Figure 31: Clinical Chemistry Market, Australia, Volume (Units), Historic, 2010-2017 104
Figure 32: Clinical Chemistry Market, Australia, Volume (Units), Forecast, 2017-2024 106
Figure 33: Blood Test Strips - Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 108
Figure 34: Clinical Chemistry Analyzers Market, Australia, Volume (Units), Historic, 2010-2017 110
Figure 35: Enzyme Chemistry Reagents Market, Australia, Volume (Units), Historic, 2010-2017 112
Figure 36: Feces Tests - Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 114
Figure 37: Substrates Market, Australia, Volume (Units), Historic, 2010-2017 116
Figure 38: Urine Testing - Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 118
Figure 39: Blood Test Strips - Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 120
Figure 40: Clinical Chemistry Analyzers Market, Australia, Volume (Units), Forecast, 2017-2024 122
Figure 41: Enzyme Chemistry Reagents Market, Australia, Volume (Units), Forecast, 2017-2024 124
Figure 42: Feces Tests - Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 126
Figure 43: Substrates Market, Australia, Volume (Units), Forecast, 2017-2024 128
Figure 44: Urine Testing - Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 130
Figure 45: Clinical Chemistry Market, Australia, Company Share (%) 2017 133
Figure 46: Genetic Testing Market, Australia, Revenue Mix ($m), 2017 135
Figure 47: Genetic Testing Market, Australia, Segment Contribution (%), 2017 136
Figure 48: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 137
Figure 49: Genetic Testing Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 139
Figure 50: Genetic Testing Market, Australia, Company Share (%) 2017 142
Figure 51: Hematology Market, Australia, Revenue Mix ($m), 2017 144
Figure 52: Hematology Market, Australia, Segment Contribution (%), 2017 145
Figure 53: Hematology Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 146
Figure 54: Hematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 148
Figure 55: Hematology Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 150
Figure 56: Hematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 152
Figure 57: Hematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 154
Figure 58: Hematology Reagents Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 156
Figure 59: Hemostasis Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 158
Figure 60: Immunohematology Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 160
Figure 61: Hematology Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 162
Figure 62: Hematology Cell Counters Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 164
Figure 63: Hematology Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 166
Figure 64: Hematology Reagents Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Figure 65: Hemostasis Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 170
Figure 66: Immunohematology Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 172
Figure 67: Hematology Market, Australia, Volume (Units), Historic, 2010-2017 174
Figure 68: Hematology Market, Australia, Volume (Units), Forecast, 2017-2024 176
Figure 69: Hematology Analyzers Market, Australia, Volume (Units), Historic, 2010-2017 178
Figure 70: Hematology Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 180
Figure 71: Hematology Reagents Market, Australia, Volume (Units), Historic, 2010-2017 182
Figure 72: Hemostasis Market, Australia, Volume (Units), Historic, 2010-2017 184
Figure 73: Hematology Analyzers Market, Australia, Volume (Units), Forecast, 2017-2024 186
Figure 74: Hematology Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 188
Figure 75: Hematology Reagents Market, Australia, Volume (Units), Forecast, 2017-2024 190
Figure 76: Hemostasis Market, Australia, Volume (Units), Forecast, 2017-2024 192
Figure 77: Hematology Market, Australia, Company Share (%) 2017 195
Figure 78: Histology And Cytology Market, Australia, Revenue Mix ($m), 2017 197
Figure 79: Histology And Cytology Market, Australia, Segment Contribution (%), 2017 198
Figure 80: Histology And Cytology Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 199
Figure 81: Histology And Cytology Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 201
Figure 82: Histology And Cytology Market, Australia, Company Share (%) 2017 204
Figure 83: Immuno Chemistry Market, Australia, Revenue Mix ($m), 2017 206
Figure 84: Immuno Chemistry Market, Australia, Segment Contribution (%), 2017 207
Figure 85: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 209
Figure 86: Immuno Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Figure 87: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 213
Figure 88: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 215
Figure 89: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 217
Figure 90: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 219
Figure 91: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 221
Figure 92: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 223
Figure 93: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 225
Figure 94: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Historic, 2010-2017 227
Figure 95: Complement Deficiency Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 229
Figure 96: Diabetes Assays Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 231
Figure 97: Disease Specific Immunochemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 233
Figure 98: Endocrinology Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 235
Figure 99: IgE Allergy Blood Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 237
Figure 100: Immunochemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 239
Figure 101: Immunochemistry Rapid Tests & POC Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 241
Figure 102: Vitamins Tests Market, Australia, Revenue ($m), USD Constant, Forecast, 2017-2024 243
Figure 103: Immuno Chemistry Market, Australia, Volume (Units), Historic, 2010-2017 245
Figure 104: Immuno Chemistry Market, Australia, Volume (Units), Forecast, 2017-2024 247
Figure 105: Complement Deficiency Tests Market, Australia, Volume (Units), Historic, 2010-2017 249
Figure 106: Diabetes Assays Market, Australia, Volume (Units), Historic, 2010-2017 251
Figure 107: Disease Specific Immunochemistry Market, Australia, Volume (Units), Historic, 2010-2017 253
Figure 108: Endocrinology Tests Market, Australia, Volume (Units), Historic, 2010-2017 255
Figure 109: IgE Allergy Blood Tests Market, Australia, Volume (Units), Historic, 2010-2017 257
Figure 110: Immunochemistry Analyzers Market, Australia, Volume (Units), Historic, 2010-2017 259
Figure 111: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Historic, 2010-2017 261
Figure 112: Vitamins Tests Market, Australia, Volume (Units), Historic, 2010-2017 263
Figure 113: Complement Deficiency Tests Market, Australia, Volume (Units), Forecast, 2017-2024 265
Figure 114: Diabetes Assays Market, Australia, Volume (Units), Forecast, 2017-2024 267
Figure 115: Disease Specific Immunochemistry Market, Australia, Volume (Units), Forecast, 2017-2024 269
Figure 116: Endocrinology Tests Market, Australia, Volume (Units), Forecast, 2017-2024 271
Figure 117: IgE Allergy Blood Tests Market, Australia, Volume (Units), Forecast, 2017-2024 273
Figure 118: Immunochemistry Analyzers Market, Australia, Volume (Units), Forecast, 2017-2024 275
Figure 119: Immunochemistry Rapid Tests & POC Market, Australia, Volume (Units), Forecast, 2017-2024 277
Figure 120: Vitamins Tests Market, Australia, Volume (Units), Forecast, 2017-2024 279
Figure 121: Immuno Ch

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human T-Lymphotropic Virus (HTLV) is a retrovirus that infects T Lymphocyte cells. There are four strains of HTLV, out of these HTLV-I and HTLV-II are the most prevalent. HTLV-I is the causative agent of two severe neurological diseases. Specifically, sources indicate that up to 3-5% of patients infected with HTLV-I develop adult T-cell Leukemia/Lymphoma (ATLL) or HTLV-I-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Conversely, HTLV-II has been linked to elevate......	$7500

Australia In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) – Global Market Analysis and Forecast Model